• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION QUANTUM MAVERICK; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION QUANTUM MAVERICK; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS Back to Search Results
Model Number 7015
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 04/02/2024
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that shaft break occurred.The 90% stenosed target lesion was located in the moderately calcified mid-to-distal segment of the left anterior descending artery.A 2.5mm x 15mm quantum maverick balloon catheter was selected for dilation.However, after opening the package and pulling out the percutaneous transluminal coronary angioplasty expansion catheter, it was noticed that the delivery catheter was fractured at 56cm from the hub.The device was immediately replaced, and no patient complications were reported.
 
Additional Manufacturer Narrative
E1.Initial reporter phone: (b)(6).
 
Additional Manufacturer Narrative
E1.Initial reporter phone: (b)(6).Device evaluated by mfr: returned product consisted of a quantum maverick balloon catheter.A visual inspection revealed that at 50cm from the strain relief, the hypotube was separated.At 49cm from the strain relief, the hypotube was kinked.A microscopic inspection revealed no further damage or irregularity.There was contrast in the inflation lumen and the balloon was tightly folded.A media depicted several photos of a portion of the device noting a separation and a kink to the hypotube of the device confirming the reported event.
 
Event or Problem Description
It was reported that shaft break occurred.The 90% stenosed target lesion was located in the moderately calcified mid-to-distal segment of the left anterior descending artery.A 2.5mm x 15mm quantum maverick balloon catheter was selected for dilation.However, after opening the package and pulling out the percutaneous transluminal coronary angioplasty expansion catheter, it was noticed that the delivery catheter was fractured at 56cm from the hub.The device was immediately replaced, and no patient complications were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
QUANTUM MAVERICK
Common Device Name
CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
pmt 741 persiaran cassia selat
bandarcassia, pulau pinan 14110
MY   14110
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key19229466
Report Number2124215-2024-24159
Device Sequence Number6732820
Product Code LOX
UDI-Device Identifier08714729392767
UDI-Public08714729392767
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
P860019
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,User Facility,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 05/24/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number7015
Device Catalogue Number7015
Device Lot Number0032601799
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 04/15/2024
Supplement Date Received by Manufacturer05/21/2024
Initial Report FDA Received Date05/02/2024
Supplement Report FDA Received Date05/24/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured10/10/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age72 YR
Patient SexUnknown
-
-